What is Pfizer Ltd. Quarterly Revenue?

Pfizer Ltd. Quarterly Revenue Pfizer Jun-2026 Quarterly Revenue is Rs 698 Cr which is growth of 4.1% YoY.

What is Pfizer Ltd. Quarterly Net Profit?

Pfizer Ltd. Quarterly Net Profit Pfizer Jun-2026 Quarterly Net Profit is Rs 204 Cr which is growth of 6.6% YoY.

What is Pfizer Ltd. Annual Revenue?

Pfizer Ltd. Annual Revenue Pfizer Mar-2026 Annual Revenue is Rs 2,708 Cr which is growth of 10.4% YoY.

What is Pfizer Ltd. Annual Net Profit?

Pfizer Ltd. Annual Net Profit Pfizer Mar-2026 Annual Net Profit is Rs 722 Cr which is growth of -5.9% YoY.

What is Pfizer Ltd. Total Shareholders Fund?

Pfizer Ltd. Total Shareholders Fund Pfizer Mar-2026 Total Shareholders Fund is Rs 4,203 Cr which is growth of -0.3% YoY.

What is Pfizer Ltd. Total Assets?

Pfizer Ltd. Total Assets Pfizer Mar-2026 Total Assets is Rs 4,922 Cr which is growth of 0.2% YoY.

What is Pfizer Ltd. Book Value Per Share?

Pfizer Ltd. Book Value Per Share Pfizer Mar-2026 Book Value Per Share is 919 Rs which is growth of -0.3% YoY.

What is Pfizer Ltd. ROE?

Pfizer Ltd. ROE Pfizer Mar-2026 ROE is 17% which is growth of 1.0% YoY.

What is Pfizer Ltd. Cash From Operating Activity?

Pfizer Ltd. Cash From Operating Activity Pfizer Mar-2026 Cash From Operating Activity is Rs 968 Cr which is growth of 46.7% YoY.

What is Pfizer Ltd. Net Cash Flow?

Pfizer Ltd. Net Cash Flow Pfizer Mar-2026 Net Cash Flow is Rs -392 Cr which is growth of -202.4% YoY.

Pfizer Ltd.

NSE: PFIZER | BSE: 500680

Falling Comet

Download real time

US FDA Inspections

33.30(0.83%)

New 52W Low in past week

17,164

NSE+BSE Volume

NSE 21 Sep, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Pfizer quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Pfizer share price target, revenues, EPS, net income and more

Pfizer quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Pfizer Jun-2026 Quarterly Revenue is Rs 698 Cr which is growth of 4.1% YoY.
POSITIVE
Quarterly Net Profit Pfizer Jun-2026 Quarterly Net Profit is Rs 204 Cr which is growth of 6.6% YoY.

Pfizer Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	698	670	683.2	684.2	670.2	636.5	580.8	631.7	604.7	621.8	575.8	611.3	564.8
SR_Q Operating Rev.	653.2	629.2	645	642.3	603.1	591.9	538	588.6	562.9	546.6	540	575.2	531.4
OI_Q Other Income	44.8	40.7	38.2	41.9	67.2	44.6	42.8	43.1	41.8	75.1	35.9	36.1	33.5
OEXPNS_Q Operating Exp.	405.6	393.3	416.8	412.4	393	364.4	392	399.3	385.4	357.2	387.4	392.6	420.7
OEXPNS_Q Operating Exp.	405.6	393.3	416.8	412.4	393	364.4	392	399.3	385.4	357.2	387.4	392.6	420.7
OP_Q Operating Profit	247.6	236	228.2	229.9	210	227.5	146	189.3	177.5	189.4	152.6	182.6	110.7
OPMPCT_Q Operating Profit Margin %	37.90%	37.50%	35.38%	35.80%	34.83%	38.43%	27.14%	32.15%	31.53%	34.65%	28.25%	31.75%	20.84%
DEP_Q Depr.	14.3	14.8	14.3	14.3	14.4	16.4	14.8	15	14.6	13.8	17.6	15.4	15.6
INT_Q Interest	1.5	2.1	2	2.1	3.3	2.7	1.5	2.1	2.1	7	2.9	2.7	2.9
PBT_Q Profit Before Tax	276.7	268.8	192	255.4	259.5	425.8	172.4	215.2	202.6	243.9	175.9	200.5	125.8
TAX_Q Tax	72.2	69	50.1	66.4	67.8	94.9	44.8	56.9	51.9	65	46	51.6	32.2
NP_Q Net Profit	204.5	199.8	141.8	189	191.8	330.9	127.6	158.4	150.7	178.9	130	149	93.5
EPS_adj_Q EPS Adj. latest	44.7	43.7	31	41.3	41.9	72.3	27.9	34.6	32.9	39.1	28.4	32.6	20.4
NP_TTM Net profit TTM	735.2	722.4	853.6	839.3	808.6	767.6	615.5	617.9	608.5	551.3	502.1	522.8	684.9
EPS_TTM Basic EPS TTM	160.7	157.9	186.6	183.5	176.8	167.8	134.5	135.1	133	120.5	109.8	114.3	149.7
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Pfizer competitor comparison and performance snapshot within industry

Pfizer revenue mix: sales, profit, and capital employed breakups by segment

Pfizer annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Pfizer Mar-2026 Annual Revenue is Rs 2,708 Cr which is growth of 10.4% YoY.
NEGATIVE
Annual Net Profit Pfizer Mar-2026 Annual Net Profit is Rs 722 Cr which is growth of -5.9% YoY.

Pfizer Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	2.3%	3.1%	2,735.4	2,707.6	2,453.6	2,373.7	2,525.8	2,673.6	2,319.7	2,335.7	2,248.9	2,082.8	2,067.4	2,099.3
TotalOperatingRevenues_A Operating Rev. Ann.	1.3%	2.4%	2,569.8	2,519.7	2,281.4	2,193.2	2,424.8	2,611	2,238.6	2,151.7	2,081.5	1,968.5	1,966.3	2,012.3
OI_A Other Income Ann.	23%	18.3%	165.6	188	172.3	180.5	101.1	62.7	81.1	184	167.4	114.3	101.2	87
OEXPNS_A Operating Exp. Ann.	0%	1.1%	1,628.1	1,615.6	1,541.1	1,557.9	1,615.9	1,775.3	1,526.4	1,579.1	1,516.3	1,468.2	1,617.1	1,580.3
OEXPNS_A Operating Exp. Ann.	0%	1.1%	1,628.1	1,615.6	1,541.1	1,557.9	1,615.9	1,775.3	1,526.4	1,579.1	1,516.3	1,468.2	1,617.1	1,580.3
OP_A Operating Profit Ann.	3.8%	4.9%	941.6	904.1	740.2	635.3	808.9	835.7	712.1	572.6	565.2	500.3	349.1	432
OPMPCT_A OPM Ann. %	1.4%	1.7%		33.39%	30.17%	26.76%	32.02%	31.26%	30.70%	24.51%	25.13%	24.02%	16.89%	20.58%
TotalExpenses_A Total Exp. Ann. ⌄	-1%	0.4%		1,682.8	1,610.3	1,635.6	1,734.8	1,900.8	1,651	1,693.2	1,589	1,534.9	1,681	1,638.8
OtherExpenses_A Other Exp. Ann.	-4%	-0.2%	360.7	363.3	359.3	417.5	410.6	423.6	367.6	422.2	444.6	414.3	516.8	515.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	3.5%	0.4%	354.2	368	371.3	347.8	331.7	403.7	361.1	364.5	323.8	314.3	303.9	277.3
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	6.3%	6.6%		1,092	912.5	815.8	909.9	898.4	793.2	756.6	732.6	614.6	450.3	519
EBIDTPCT_A EBITDA Ann. margin %	3.8%	3.4%		40.33%	37.19%	34.37%	36.02%	33.60%	34.20%	32.39%	32.58%	29.51%	21.78%	24.72%
INT_A Interest Ann.	-10.8%	-8.9%	7.7	9.5	8.4	15.4	13.4	10.5	15.1	10.9	1.3	0.4	1	0.5
DEP_A Depr.	-18.2%	-12%	57.6	57.7	60.8	62.3	105.5	115	109.4	103.2	71.4	66.3	62.9	57.9
PBT_A PBT Ann.	5.8%	7.8%	992.8	975.7	1,016.1	746.1	824	772.9	668.7	642.5	659.9	547.9	516.8	470.4
TAX_A Tax Ann.	8.2%	8.2%	257.7	253.2	248.5	194.7	200.1	160.3	171.1	133.4	230.9	187.8	180.1	165.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	5%	7.7%		722.4	767.6	551.3	623.9	612.6	497.6	509.1	429.1	360.1	336.8	305
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	5%	7.7%	735.2	722.4	767.6	551.3	623.9	612.6	497.6	509.1	429.1	360.1	336.8	305
NETPCT_A NPM Ann. %	3.7%	5.2%		28.67%	33.64%	25.13%	25.73%	23.46%	22.22%	23.66%	20.61%	18.29%	17.12%	15.15%
EPS_adj_A EPS Adj. latest Ann.	5%	7.7%		157.9	167.8	120.5	136.4	133.9	108.8	111.3	93.8	78.7	73.6	66.7
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

10.4%

2Y CAGR

6.8%

3Y CAGR

2.3%

5Y CAGR

3.1%

7Y CAGR

2.7%

10Y CAGR

2.6%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

-5.9%

2Y CAGR

14.5%

3Y CAGR

5Y CAGR

7.7%

7Y CAGR

7.7%

10Y CAGR

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

4.8%

2Y CAGR

1.8%

3Y CAGR

5Y CAGR

1.1%

7Y CAGR

0.9%

10Y CAGR

0.2%

Operating Expenses Annual Cr growth is higher than historical averages.

Pfizer balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund Pfizer Mar-2026 Total Shareholders Fund is Rs 4,203 Cr which is growth of -0.3% YoY.
POSITIVE
Total Assets Pfizer Mar-2026 Total Assets is Rs 4,922 Cr which is growth of 0.2% YoY.

Pfizer Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	9.4%	11.9%	4,202.9	4,217.4	3,595.5	3,207.3	2,864.4	2,393	3,395.5	3,011.3	2,683.2	2,418.9	2,163.5
EQCAP_A Equity Share Capital Ann.	0%	0%	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8
TotalShareCapital_A Total Share Capital Ann.	0%	0%	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8	45.8
ReservesAndSurplus_A Reserves Plus Surplus Ann.	9.6%	12.1%	4,157.2	4,171.7	3,549.8	3,161.6	2,818.7	2,347.3	3,349.7	2,965.6	2,637.5	2,373.1	2,117.8
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	9.6%	12.1%	4,157.2	4,171.7	3,549.8	3,161.6	2,818.7	2,347.3	3,349.7	2,965.6	2,637.5	2,373.1	2,117.8
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-12.4%	-1.5%	91.5	124.2	86.7	136.1	183.2	98.5	136.6	37	52.3	62.4	66.1
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-								2.2	14.6	17.6	28.2
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-22.5%	0.3%	43.4	67.6	54.4	93.3	127.7	42.7	88.7				0.1
CL_A Total Current Liabilities Ann. ⌄	-1.5%	-4.1%	627.5	569.5	546.6	657.4	852.9	774.3	873.4	891.7	954.4	779.7	658.4
TradePayables_A Trade Payables Ann.	-0.2%	-5.3%	215.9	151.6	166.2	217.1	263.9	283.7	426.8	435.9			337.9
OtherCurrentLiabilities_A Other Current Liabilities Ann.	3.9%	-1.5%	378.8	364.1	332.9	337.3	507.9	407.5	386.4	390.9	888.4	719	265.5
ShortTermProvisions_A ST Provisions Ann.	-32.9%	-17.8%	30.3	51.3	45	100.5	78.6	80.6	57.7	62.4	63.5	58.2	55
TL_A Total Capital Plus Liabilities Ann.	7.2%	8.5%	4,921.9	4,911.1	4,228.8	4,000.7	3,900.5	3,265.9	4,405.4	3,940	3,690	3,261	2,888.1
FixedAssets_A Fixed Assets Ann. ⌄	-2.7%	-4.9%	698	731.3	713.1	757.2	870.3	897.1	973.6	886.2	951.4	906.1	964.6
TangibleAssets_A Tangible Assets Ann.	-8.5%	-6.7%	136.1	171.8	151	177.5	218.9	192.4	214.5	71.4	81.5	83.3	98.3
IntangibleAssets_A Intangible Assets Ann.	-1.8%	-4.2%	541.8	551.8	561.8	571.7	622	672.4	727.4	782.4	527.5	527.5	826.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	36.3%	48.2%	20	7.6	0.4	7.9	1.2	2.8	0.8		1	3.9	3.3
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-8.8%	-3.6%	1,118.7	1,398.3	1,459.2	1,475.6	1,504	1,341.2	1,357.2	1,223.3	1,273.2	1,209.7	1,255.6
NonCurrentInvestments_A Non Current Investments Ann.	-	-
DeferredTaxAssets_A Deferred Tax Assets Ann.	-9.5%	39.9%	72.3	69.3	53.9	97.7	47	13.5	0.6
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-					0.4	32.3	31.9	31.8	43.3	32.1	30.6
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-17.5%	-2.6%	348.4	597.7	692.2	620.8	586.4	398.4	351	305.4	278.6	271.4	260.3
CA_A Total Current Assets Ann. ⌄	14.6%	14.6%	3,803.2	3,512.9	2,769.6	2,525.1	2,396.5	1,924.7	3,048.3	2,716.7	2,416.7	2,051.3	1,613.9
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	6.2%	7%	181.8	193.1	187.6	151.7	124.3	129.7	172	171.7	154.8	110.3	142.3
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	18.7%	22.8%	3,110.8	2,801	2,046.7	1,859.5	1,633.3	1,115.1	2,219.9	1,914.3	1,771.9	1,523.1	1,024.7
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-					0.3	8.6	3.5	5.4	28	27	24.7
OtherCurrentAssets_A Other Current Assets Ann.	-26.6%	-30.6%	38	42.9	101.6	96.1	189.7	236.3	222.2	238.6	165	69	80.1
TA_A Total Assets Ann.	7.2%	8.5%	4,921.9	4,911.1	4,228.8	4,000.7	3,900.5	3,265.9	4,405.4	3,940	3,690	3,261	2,888.1
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-5.3%	7.9%	372.2	364.7	533.8	437.8	338.1	255	254.6	219.1	471.9	498.6	689.4
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	19.1	19.1	19.1	19.1	19.1	19.1	19.1	19.1	19.1	19.1	19.1
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

0.2%

2Y CAGR

7.9%

3Y CAGR

7.2%

5Y CAGR

8.5%

7Y CAGR

3.2%

10Y CAGR

5.5%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

10.2%

2Y CAGR

7.1%

3Y CAGR

-1.5%

5Y CAGR

-4.1%

7Y CAGR

-4.9%

10Y CAGR

-0.5%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

-0.3%

2Y CAGR

8.1%

3Y CAGR

9.4%

5Y CAGR

11.9%

7Y CAGR

4.9%

10Y CAGR

6.9%

Total ShareHolders Funds Annual is falling faster than historical averages.

Pfizer ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Pfizer Mar-2026 Book Value Per Share is 919 Rs which is growth of -0.3% YoY.
POSITIVE
ROE Pfizer Mar-2026 ROE is 17% which is growth of 1.0% YoY.

Pfizer Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	9.4%	11.9%	918.7	921.8	785.9	701.1	626.1	523.1	742.2	658.2	586.5	528.7	472.9
ROA_A RoA Ann. %	-2%	-0.7%	14.67%	15.62%	13.03%	15.59%	15.70%	15.23%	11.55%	10.88%	9.75%	10.32%	10.56%
ROE_A ROE Ann. %	-4.1%	-3.7%	17.18%	18.20%	15.33%	19.45%	21.38%	20.79%	14.99%	14.24%	13.41%	13.92%	14.09%
ROCE_A ROCE Ann. %	0%	-2.6%	24.08%	19.61%	20.46%	24.05%	25.70%	27.44%	18.49%	21.69%	20.04%	15.61%	20.67%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	4.9%	4.1%	43.34%	39.99%	37.19%	37.52%	34.40%	35.43%	35.16%	35.19%	31.22%	22.90%	25.79%
PBITMargin_A EBIT Ann. Margin %	7.4%	6.1%	41.04%	37.33%	34.35%	33.17%	30.00%	30.54%	30.36%	31.76%	27.85%	19.70%	22.91%
PBTMargin_A PBT Ann. Margin %	4.4%	5.3%	38.72%	44.53%	34.01%	33.98%	29.60%	29.87%	29.86%	31.70%	27.83%	26.28%	23.37%
NETPCT_A NPM Ann. %	3.7%	5.2%	28.67%	33.64%	25.13%	25.73%	23.46%	22.22%	23.66%	20.61%	18.29%	17.12%	15.15%
ASETTO_A Asset Turnover Ann. %	-5.9%	-3.6%	0.5	0.5	0.5	0.6	0.7	0.6	0.5	0.6	0.6	0.6	0.7
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	17.1%	19.5%	6.1	6.2	5.1	3.8	2.8	2.5	3.5	3.1	2.5	2.6	2.5
QuickRatio_A Quick Ratio Ann.	18.3%	22.8%	5.3	5.3	4.3	3.2	2.3	1.9	3	2.6	2.2	2.2	1.9
DividendPayoutNP_A Dividend Payout to NP Ann.	26%	-19.7%	1	0.2	0.3	0.5	0.3	3	0.2	0.2	0.3	0.2	0.2
EarningRetention_A Earning Retention Ann. %	-	-	-4.48%	79.14%	66.81%	52.35%	73.87%	-203.38%	75.63%	74.30%	69.42%	75.48%	77.44%
CashEarningRetention_A Cash Earning Retention Ann. %	-62%	-	3.25%	80.67%	70.18%	59.24%	78.00%	-148.70%	79.74%	77.96%	74.17%	79.34%	81.04%
CashEarningRetention_A Cash Earning Retention Ann. %	-62%	-	3.25%	80.67%	70.18%	59.24%	78.00%	-148.70%	79.74%	77.96%	74.17%	79.34%	81.04%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	9.7%	-1.1%	18,484.6	15,519.6	17,140.8	13,990.3	18,276.4	19,572.8	16,195.4	13,279.9	8,228.6	7,137.4	7,151.2
EVPerNetSales_A EV Per Net Sales Ann.	8%	-3.4%	7.3	6.8	7.8	5.8	7	8.7	7.5	6.4	4.2	3.6	3.6
PBV_A Price To Book Value Adjusted	-8.7%	-10.7%	4.39	4.92	5.14	5.76	6.45	7.72	5.44	6.13	6.88	7.63	8.53
EVPerEBITDA_A EV Per EBITDA Ann.	3.1%	-7.3%	16.9	17	21	15.4	20.3	24.7	21.4	18.1	13.4	15.9	13.8
MarketCapPerSales_A Market Cap Per Sales Ann.	9.8%	-1.3%	8.6	8	8.8	6.5	7.6	9.2	8.6	7.3	5.1	4.4	4.1
RetentionRatios_A Retention Ratio Ann. %	-	-	-4.48%	79.13%	66.80%	52.34%	73.86%	-203.38%	75.62%	74.29%	69.41%	75.47%	77.43%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-5.6%

2Y CAGR

5.9%

3Y CAGR

-4.1%

5Y CAGR

-3.7%

7Y CAGR

2.7%

10Y CAGR

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-6.1%

2Y CAGR

6.1%

3Y CAGR

-2%

5Y CAGR

-0.7%

7Y CAGR

4.4%

10Y CAGR

3.3%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-1.6%

2Y CAGR

9.4%

3Y CAGR

17.1%

5Y CAGR

19.5%

7Y CAGR

10.2%

10Y CAGR

9.3%

Current Ratio Annual is falling faster than historical averages.

Pfizer cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Pfizer Mar-2026 Cash From Operating Activity is Rs 968 Cr which is growth of 46.7% YoY.
NEGATIVE
Net Cash Flow Pfizer Mar-2026 Net Cash Flow is Rs -392 Cr which is growth of -202.4% YoY.

Pfizer Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	39.6%	17.8%	967.6	659.8	256.8	355.7	667.1	427.3	323.2	97.8	331.8	328.8	345.5
PBT_A PBT Ann.	5.8%	7.8%	975.7	1,016.1	746.1	824	772.9	668.7	642.5	659.9	547.9	516.8	470.4
INT_A Interest Ann.	-10.8%	-8.9%	9.5	8.4	15.4	13.4	10.5	15.1	10.9	1.3	0.4	1	0.5
TAX_A Tax Ann.	8.2%	8.2%	253.2	248.5	194.7	200.1	160.3	171.1	133.4	230.9	187.8	180.1	165.4
CFI_A Cash from Investing Act. Ann.	-	-	-561.7	-71.3	53.7	-36.1	-575	-468.8	1,530.3	35.1	-238.3	-249.6	-700.9
CFA_A Cash from Financing Act. Ann.	-	-	-798.3	-205.3	-235.1	-345.8	-180.5	-1,571.1	-163.5	-109.9	-110.4	-82.6	-61.9
NCF_A Net Cash Flow Ann. ⌄	-	-	-392.4	383.1	75.4	-26.2	-88.5	-1,612.6	1,690	23.1	-16.9	-3.4	-417.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	99%	-22.4%	495.1	112	36.6	62.8	151.2	1,763.8	73.8	50.7	67.6	71.1	488.4
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	41%	-7.4%	102.7	495.1	112	36.6	62.8	151.2	1,763.8	73.8	50.7	67.6	71.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

46.7%

2Y CAGR

94.1%

3Y CAGR

39.6%

5Y CAGR

17.8%

7Y CAGR

38.7%

10Y CAGR

10.8%

Cash from Operating Activity Annual growth is higher than historical averages.

Pfizer investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

New 52W Low in past week

Pfizer quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Pfizer - Forecaster

Forecaster Analyst Estimates for Pfizer share price target, revenues, EPS, net income and more